ArticleThe Journal of biological chemistry2017

The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice.

Niharika Amireddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.